Imeik Technology Development Co.,Ltd.

300896

CNE100004868

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
297 ^CNY	+1.31%		+6.26%	+0.91%

Apr. 24	Imeik Technology Development Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 20	Imeik Technology Development's Profit Rises 47% on Higher Revenue	MT

Imeik Technology Development Co.,Ltd. Proposes Final Cash Dividend for 2022

March 09, 2023 at 02:33 pm EST

Imeik Technology Development Co.,Ltd. proposed final Cash dividend/10 shares (tax included): CNY 28.00000000 for 2022.

Latest news about Imeik Technology Development Co.,Ltd.

Imeik Technology Development Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Imeik Technology Development's Profit Rises 47% on Higher Revenue	Mar. 20	MT
Imeik Technology Development Co.,Ltd. Proposes Final Dividend for the Year 2023	Mar. 19	CI
Imeik Technology Development Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
Tranche Update on Imeik Technology Development Co.,Ltd.'s Equity Buyback Plan announced on June 12, 2023.	Dec. 08	CI
Imeik Technology Development Co.,Ltd.'s Equity Buyback announced on June 12, 2023, has closed with 1,165,874 shares, representing 0.54% for CNY 399.69 million.	Dec. 06	CI
QL Biopharmaceutical announced that it has received CNY 200 million in funding from BlueRun Investment Consulting Co., Ltd., Imeik Technology Development Co.,Ltd., China-US Green Fund Management Co., Ltd., Shenzhen Jiayuan Capital Management Co., Ltd., Chengdu Science and Technology Innovation Investment Group Co., Ltd., Shanghai Jincheng Equity Investment Fund Management Co., Ltd. and other investors	Nov. 26	CI
Imeik Technology Wins Exclusive Rights to Distribute Jeisys’ Aesthetic Equipment in China	Nov. 09	MT
Imeik Technology Development Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Tranche Update on Imeik Technology Development Co.,Ltd.'s Equity Buyback Plan announced on June 12, 2023.	23-10-18	CI
Imeik Technology Development Co.,Ltd. Approves Cash Distribution for the First Half of 2023, Payable on 23 October 2023	23-09-14	CI
Imeik Technology Development Co.,Ltd. Proposes Distribution for the First Half of 2023	23-08-25	CI
Imeik Technology Development's Profit Jumps 65.7% in H1	23-08-25	MT
Imeik Technology Development Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Tranche Update on Imeik Technology Development Co.,Ltd.'s Equity Buyback Plan announced on June 12, 2023.	23-07-03	CI
Imeik Technology Development Co.,Ltd. announces an Equity Buyback for CNY 400 million worth of its shares.	23-06-12	CI
Imeik Technology Development Co.,Ltd. authorizes a Buyback Plan.	23-06-11	CI
Imeik Technology Development Co.,Ltd. Declares 2022 Final Profit Distribution, Payable on 15 May 2023	23-05-08	CI
Imeik Technology Development Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Imeik Technology Development Co.,Ltd. Proposes Final Cash Dividend for 2022	23-03-09	CI
Imeik Technology’s Profit Jumps 32% as Revenue Rises 34% in 2022	23-03-08	MT
Imeik Technology Development Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-08	CI
Imeik Technology Development Co.,Ltd. Approves Director Appointments	22-11-18	CI
Imeik Technology’s Profit Jumps 42% as Revenue Rises 55% in Q3	22-10-26	MT
Imeik Technology Development Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI

Chart Imeik Technology Development Co.,Ltd.

Duration

Period

Chart Imeik Technology Development Co.,Ltd.

More charts

Imeik Technology Development Co Ltd is a China-based company mainly engaged in the research and development, production and sales of biomedical materials. The Company focuses on the development and transformation of biomedical materials, and is committed to the development of biomedicine such as recombinant proteins and peptides. The Company has realized the industrialization of injection-type sodium hyaluronate series products and polydioxanone facial implants, and has established a product technology transformation platform for biomedical materials such as medical chitosan and polylactic acid. The Company's self-developed products are mainly aimed at the repair of fold skin on the face and neck. The clinical applications of its products cover medical cosmetology, surgical repair, and treatment of metabolic diseases. The Company mainly conducts its businesses in the China market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Imeik Technology Development Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

297 CNY

Average target price

313 CNY

Spread / Average Target

+5.37%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.91%	8.82B
STRYKER CORPORATION	+12.07%	128B
SMITH & NEPHEW PLC	-8.52%	10.65B
INSPIRE MEDICAL SYSTEMS, INC.	+16.72%	7.19B
GLAUKOS CORPORATION	+25.15%	4.99B
AXONICS, INC.	+7.17%	3.4B
ENOVIS CORPORATION	-1.36%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.73%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.15%	2B
DOUBLE MEDICAL TECHNOLOGY INC.	-22.81%	1.79B

Medical Devices & Implants